Stefano Ciampolini

Stefano Ciampolini is an Honorary Fellow of Imperial College Business School in London and Mentor at Imperial Enterprise Lab’s Venture Mentoring Service as well as a member of the Chair of Entrepreneurship at the Swiss Federal Institute of Technology (ETH Zurich). Stefano is also a jury member of Venture Kick, Switzerland’s largest startup accelerator program.

Stefano is a serial healthcare and medical technology entrepreneur in Europe and the US having founded and successfully exited several companies in the dialysis and renal care sector over the last 25 years.

He is also a managing partner and founder at MedScience Ventures (Boston), a life sciences venture capital fund, and managing partner and founder of Healthcare Capital Partners (London), a private equity and corporate finance advisory boutique specialising in life sciences.

As part of his activities Stefano is a founder, board member and investor in several healthcare and medtech ventures and private equity funds focusing on healthcare investments in Europe and the US. He is founder of Renal Services, a UK dialysis company now part of DaVita, founder and board member of Pure Life Renal, a US dialysis services company, founder and co-chairman of Renal@Home, a remote patient monitoring company, founder and board member of UV Light Care, a US medical devices company, chairman of the board of Sleepiz, a Swiss respiratory medical devices company spun out of ETH, a board member of YoFumo Technologies, a US biomass decontamination company, a board member of Pathfinder Medical, a medical devices company spun out of Imperial College, and an advisory board member to Spiden, a Swiss medtech company.

Stefano earned an MBA from Imperial College Business School in London in 1994 and holds a degree in economics from Kingston University in London.